Bellevue Group »

Praxis Precision Medicines I shares owned by Bellevue Group

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Bellevue Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $566k 1.8k 322.19

More positions owned by Bellevue Group

Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Regeneron Pharmaceuticals (REGN)
Scholar Rock Hldg Corp (SRRK)
Gilead Sciences (GILD)
Revolution Medicines (RVMD)
Ionis Pharmaceuticals (IONS)
Intuitive Surgical Com New (ISRG)
Miragen Therapeutics (VRDN)
Krystal Biotech (KRYS)
Crinetics Pharmaceuticals In (CRNX)
Abbott Laboratories (ABT)
Nuvalent Inc-a (NUVL)
Amgen (AMGN)
Boston Scientific Corporation (BSX)

View all positions for Bellevue Group

Top funds holding Praxis Precision Medicines I

Henderson Group
Orbis Allan Gray
BlackRock
FMR
Perceptive Advisors
Baker Bros. Advisors
Vanguard Capital Management
Deerfield Management Company
Driehaus Capital Management
Cormorant Asset Management
State Street Corporation
Morgan Stanley
Adage Capital Partners GP
Vanguard Portfolio Management
Goldman Sachs Group

View all funds holding Praxis Precision Medicines I